Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 102

    1.

    Safety and feasibility of achieving lower systolic blood pressure goals in persons with type 2 diabetes: the SANDS trial.

    Weir MR, Yeh F, Silverman A, Devereux RB, Galloway JM, Henderson JA, Howard WJ, Russell M, Wilson C, Ratner R, Sorkin J, Umans JG, Fleg JL, Stylianou M, Lee E, Howard BV.

    J Clin Hypertens (Greenwich). 2009 Oct;11(10):540-8.PMID: 19817934 [PubMed - in process]Related articles

    2.

    Actos Now for the prevention of diabetes (ACT NOW) study.

    Defronzo RA, Banerji M, Bray GA, Buchanan TA, Clement S, Henry RR, Kitabchi AE, Mudaliar S, Musi N, Ratner R, Reaven PD, Schwenke D, Stentz FB, Tripathy D.

    BMC Endocr Disord. 2009 Jul 29;9:17.PMID: 19640291 [PubMed - in process]Related articlesFree article

    3.

    Effects of therapy in type 1 and type 2 diabetes mellitus with a peptide derived from islet neogenesis associated protein (INGAP).

    Dungan KM, Buse JB, Ratner RE.

    Diabetes Metab Res Rev. 2009 Sep;25(6):558-65.PMID: 19626663 [PubMed - in process]Related articles

    4.

    Risk factors associated with methamphetamine use and heart failure among native Hawaiians and other Pacific Island peoples.

    Mau MK, Asao K, Efird J, Saito E, Ratner R, Hafi M, Seto T.

    Vasc Health Risk Manag. 2009;5(1):45-52. Epub 2009 Apr 8.PMID: 19436660 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial.

    Young LH, Wackers FJ, Chyun DA, Davey JA, Barrett EJ, Taillefer R, Heller GV, Iskandrian AE, Wittlin SD, Filipchuk N, Ratner RE, Inzucchi SE; DIAD Investigators.

    JAMA. 2009 Apr 15;301(15):1547-55.PMID: 19366774 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    A 24-week, multicenter, open-label, randomized study to compare changes in glucose metabolism in patients with schizophrenia receiving treatment with olanzapine, quetiapine, or risperidone.

    Newcomer JW, Ratner RE, Eriksson JW, Emsley R, Meulien D, Miller F, Leonova-Edlund J, Leong RW, Brecher M.

    J Clin Psychiatry. 2009 Apr;70(4):487-99. Epub 2009 Apr 7.PMID: 19358783 [PubMed - indexed for MEDLINE]Related articles

    8.

    [Nutritional status and lifestyles of workers from two regions in Chile]

    Ratner R, Sabal J, Hernández P, Romero D, Atalah E.

    Rev Med Chil. 2008 Nov;136(11):1406-14. Spanish. PMID: 19301771 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effect of progression from impaired glucose tolerance to diabetes on cardiovascular risk factors and its amelioration by lifestyle and metformin intervention: the Diabetes Prevention Program randomized trial by the Diabetes Prevention Program Research Group.

    Goldberg RB, Temprosa M, Haffner S, Orchard TJ, Ratner RE, Fowler SE, Mather K, Marcovina S, Saudek C, Matulik MJ, Price D; Diabetes Prevention Program Research Group.

    Diabetes Care. 2009 Apr;32(4):726-32. Epub 2009 Jan 26.PMID: 19171717 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial.

    Fleg JL, Mete M, Howard BV, Umans JG, Roman MJ, Ratner RE, Silverman A, Galloway JM, Henderson JA, Weir MR, Wilson C, Stylianou M, Howard WJ.

    J Am Coll Cardiol. 2008 Dec 16;52(25):2198-205.PMID: 19095139 [PubMed - indexed for MEDLINE]Related articles

    11.

    Assessment on the Prevention of Progression by Rosiglitazone on Atherosclerosis in diabetes patients with Cardiovascular History (APPROACH): study design and baseline characteristics.

    Ratner RE, Cannon CP, Gerstein HC, Nesto RW, Serruys PW, Van Es GA, Kolatkar NS, Kravitz BG, Zalewski A, Fitzgerald PJ; APPROACH Study Group.

    Am Heart J. 2008 Dec;156(6):1074-9. Epub 2008 Oct 11.PMID: 19033001 [PubMed - indexed for MEDLINE]Related articles

    12.

    Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions.

    Ratner RE, Christophi CA, Metzger BE, Dabelea D, Bennett PH, Pi-Sunyer X, Fowler S, Kahn SE; Diabetes Prevention Program Research Group.

    J Clin Endocrinol Metab. 2008 Dec;93(12):4774-9. Epub 2008 Sep 30.PMID: 18826999 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial.

    Garber A, Henry R, Ratner R, Garcia-Hernandez PA, Rodriguez-Pattzi H, Olvera-Alvarez I, Hale PM, Zdravkovic M, Bode B; LEAD-3 (Mono) Study Group.

    Lancet. 2009 Feb 7;373(9662):473-81. Epub 2008 Sep 24.PMID: 18819705 [PubMed - indexed for MEDLINE]Related articles

    14.

    Combination pharmacotherapy with incretins: what works best and when?

    Over RK, Ratner RE.

    Curr Diab Rep. 2008 Oct;8(5):361-7.PMID: 18778584 [PubMed - indexed for MEDLINE]Related articles

    15.

    Approach to the patient with prediabetes.

    Aroda VR, Ratner R.

    J Clin Endocrinol Metab. 2008 Sep;93(9):3259-65. Review.PMID: 18772457 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study.

    Schwartz SL, Ratner RE, Kim DD, Qu Y, Fechner LL, Lenox SM, Holcombe JH.

    Clin Ther. 2008 May;30(5):858-67.PMID: 18555933 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial.

    Howard BV, Roman MJ, Devereux RB, Fleg JL, Galloway JM, Henderson JA, Howard WJ, Lee ET, Mete M, Poolaw B, Ratner RE, Russell M, Silverman A, Stylianou M, Umans JG, Wang W, Weir MR, Weissman NJ, Wilson C, Yeh F, Zhu J.

    JAMA. 2008 Apr 9;299(14):1678-89.PMID: 18398080 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Evaluating the cardiovascular effects of the thiazolidinediones and their place in the management of type 2 diabetes in relation to the metabolic syndrome.

    Drexler AJ, Nesto RW, Abrahamson MJ, Bakris G, Bell D, Brunzell J, Dandona P, Davidson J, Fonseca V, Fowler M, Frye R, Giles T, Haffner S, Hollenberg N, Hsueh W, Law R, Plutzky J, Ratner R, Reusch J, Selwyn A, Sowers J, Wyne K, Young LH.

    Metab Syndr Relat Disord. 2005 Summer;3(2):147-73.PMID: 18370723 [PubMed - in process]Related articles

    19.

    Prevention of type 2 diabetes in women with previous gestational diabetes.

    Ratner RE.

    Diabetes Care. 2007 Jul;30 Suppl 2:S242-5. Review. No abstract available. Erratum in: Diabetes Care. 2007 Dec;30(12):3154. PMID: 17596479 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Efficacy, safety and tolerability of tesaglitazar when added to the therapeutic regimen of poorly controlled insulin-treated patients with type 2 diabetes.

    Ratner RE, Parikh S, Tou C; GALLANT 9 Study Group.

    Diab Vasc Dis Res. 2007 Sep;4(3):214-21.PMID: 17907111 [PubMed - indexed for MEDLINE]Related articles

    21.

    Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults.

    Hoerger TJ, Hicks KA, Sorensen SW, Herman WH, Ratner RE, Ackermann RT, Zhang P, Engelgau MM.

    Diabetes Care. 2007 Nov;30(11):2874-9. Epub 2007 Aug 13.PMID: 17698614 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Resolution of asymptomatic myocardial ischemia in patients with type 2 diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study.

    Wackers FJ, Chyun DA, Young LH, Heller GV, Iskandrian AE, Davey JA, Barrett EJ, Taillefer R, Wittlin SD, Filipchuk N, Ratner RE, Inzucchi SE; Detection of Ischemia in Asymptomatic Diabetics (DIAD) Investigators.

    Diabetes Care. 2007 Nov;30(11):2892-8. Epub 2007 Aug 6.PMID: 17682123 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Incretin-based therapies for type 2 diabetes: clinical utility.

    Ratner R.

    Endocrinol Metab Clin North Am. 2006 Dec;35 Suppl 1:12-6; discussion 17-19. Review. No abstract available. PMID: 17424675 [PubMed - indexed for MEDLINE]Related articles

    24.

    Differential effects of oral hypoglycemic agents on glucose control and cardiovascular risk.

    Uwaifo GI, Ratner RE.

    Am J Cardiol. 2007 Feb 19;99(4A):51B-67B. Epub 2006 Dec 27. Review.PMID: 17307058 [PubMed - indexed for MEDLINE]Related articles

    25.

    Exenatide and pramlintide: new therapies for diabetes.

    Want LL, Ratner R.

    Int J Clin Pract. 2006 Dec;60(12):1522-3. No abstract available. PMID: 17109659 [PubMed - indexed for MEDLINE]Related articles

    26.

    Pramlintide: A new tool in diabetes management.

    Want LL, Ratner RE.

    Curr Diab Rep. 2006 Nov;6(5):344-9. Review.PMID: 17076994 [PubMed - indexed for MEDLINE]Related articles

    27.

    Examination of lower targets for low-density lipoprotein cholesterol and blood pressure in diabetes--the Stop Atherosclerosis in Native Diabetics Study (SANDS).

    Russell M, Fleg JL, Galloway WJ, Henderson JA, Howard J, Lee ET, Poolaw B, Ratner RE, Roman MJ, Silverman A, Stylianou M, Weir MR, Wilson C, Yeh F, Zhu J, Howard BV.

    Am Heart J. 2006 Nov;152(5):867-75.PMID: 17070147 [PubMed - indexed for MEDLINE]Related articles

    28.

    Total carnitine and acylated carnitine ratio: relationship of free carnitine with lipid parameters in pediatric dialysis patients.

    Marín VB, Azocar M, Molina M, Guerrero JL, Ratner R, Cano F.

    Adv Perit Dial. 2006;22:130-5.PMID: 16983956 [PubMed - indexed for MEDLINE]Related articles

    29.

    Ethnic differences in perinatal outcome of gestational diabetes mellitus.

    Silva JK, Kaholokula JK, Ratner R, Mau M.

    Diabetes Care. 2006 Sep;29(9):2058-63.PMID: 16936153 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Long-term effects of exenatide therapy over 82 weeks on glycaemic control and weight in over-weight metformin-treated patients with type 2 diabetes mellitus.

    Ratner RE, Maggs D, Nielsen LL, Stonehouse AH, Poon T, Zhang B, Bicsak TA, Brodows RG, Kim DD.

    Diabetes Obes Metab. 2006 Jul;8(4):419-28.PMID: 16776749 [PubMed - indexed for MEDLINE]Related articles

    31.

    Value of peripheral vascular endothelial function in the detection of relative myocardial ischemia in asymptomatic type 2 diabetic patients who underwent myocardial perfusion imaging.

    Papaioannou GI, Kasapis C, Seip RL, Grey NJ, Katten D, Wackers FJ, Inzucchi SE, Engel S, Taylor A, Young LH, Chyun DA, Davey JA, Iskandrian AE, Ratner RE, Robinson EC, Carolan S, Heller GV.

    J Nucl Cardiol. 2006 May-Jun;13(3):362-8.PMID: 16750781 [PubMed - indexed for MEDLINE]Related articles

    32.

    An evaluation of cost sharing to finance a diet and physical activity intervention to prevent diabetes.

    Ackermann RT, Marrero DG, Hicks KA, Hoerger TJ, Sorensen S, Zhang P, Engelgau MM, Ratner RE, Herman WH.

    Diabetes Care. 2006 Jun;29(6):1237-41.PMID: 16732002 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    An update on the Diabetes Prevention Program.

    Ratner RE; Diabetes Prevention Program Research.

    Endocr Pract. 2006 Jan-Feb;12 Suppl 1:20-4. Review.PMID: 16627375 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    [Dialysis dose, nutrition and growth among pediatric patients on peritoneal dialysis]

    Cano F, Azócar M, Marín V, Rodríguez E, Delucchi A, Ratner R, Cavada G.

    Rev Med Chil. 2005 Dec;133(12):1455-64. Epub 2006 Jan 27. Spanish. PMID: 16446873 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors.

    Howard BV, Best LG, Galloway JM, Howard WJ, Jones K, Lee ET, Ratner RE, Resnick HE, Devereux RB.

    Diabetes Care. 2006 Feb;29(2):391-7.PMID: 16443893 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Managing people at high risk for diabetes.

    Herman WH, Hoerger TJ, Hicks K, Brandle M, Sorensen SW, Zhang P, Engelgau MM, Hamman RF, Marrero DG, Ackermann RT, Ratner RE.

    Ann Intern Med. 2006 Jan 3;144(1):66-7; author reply 67-8. No abstract available. PMID: 16389262 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    How subjective grouping of options influences choice and allocation: diversification bias and the phenomenon of partition dependence.

    Fox CR, Ratner RK, Lieb DS.

    J Exp Psychol Gen. 2005 Nov;134(4):538-51.PMID: 16316290 [PubMed - indexed for MEDLINE]Related articles

    39.

    Impact of computer-generated personalized goals on cholesterol lowering.

    Levetan CS, Dawn KR, Murray JF, Popma JJ, Ratner RE, Robbins DC.

    Value Health. 2005 Nov-Dec;8(6):639-46.PMID: 16283864 [PubMed - indexed for MEDLINE]Related articles

    40.

    Adjunctive therapy with pramlintide lowers HbA1c without concomitant weight gain and increased risk of severe hypoglycemia in patients with type 1 diabetes approaching glycemic targets.

    Ratner R, Whitehouse F, Fineman MS, Strobel S, Shen L, Maggs DG, Kolterman OG, Weyer C.

    Exp Clin Endocrinol Diabetes. 2005 Apr;113(4):199-204.PMID: 15891954 [PubMed - indexed for MEDLINE]Related articles

    41.

    Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes.

    DeFronzo RA, Ratner RE, Han J, Kim DD, Fineman MS, Baron AD.

    Diabetes Care. 2005 May;28(5):1092-100.PMID: 15855572 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance.

    Haffner S, Temprosa M, Crandall J, Fowler S, Goldberg R, Horton E, Marcovina S, Mather K, Orchard T, Ratner R, Barrett-Connor E; Diabetes Prevention Program Research Group.

    Diabetes. 2005 May;54(5):1566-72.PMID: 15855347 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial.

    Orchard TJ, Temprosa M, Goldberg R, Haffner S, Ratner R, Marcovina S, Fowler S; Diabetes Prevention Program Research Group.

    Ann Intern Med. 2005 Apr 19;142(8):611-9.PMID: 15838067 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program.

    Ratner R, Goldberg R, Haffner S, Marcovina S, Orchard T, Fowler S, Temprosa M; Diabetes Prevention Program Research Group.

    Diabetes Care. 2005 Apr;28(4):888-94.PMID: 15793191 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Novel pharmacologic agents for type 2 diabetes.

    Uwaifo GI, Ratner RE.

    Endocrinol Metab Clin North Am. 2005 Mar;34(1):155-97. Review.PMID: 15752927 [PubMed - indexed for MEDLINE]Related articles

    46.

    The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance.

    Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, Hamman RF, Ackermann RT, Engelgau MM, Ratner RE; Diabetes Prevention Program Research Group.

    Ann Intern Med. 2005 Mar 1;142(5):323-32.PMID: 15738451 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes.

    Levy AP, Gerstein HC, Miller-Lotan R, Ratner R, McQueen M, Lonn E, Pogue J.

    Diabetes Care. 2004 Nov;27(11):2767. No abstract available. PMID: 15505023 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus: a 1-year, randomized controlled trial.

    Ratner RE, Dickey R, Fineman M, Maggs DG, Shen L, Strobel SA, Weyer C, Kolterman OG.

    Diabet Med. 2004 Nov;21(11):1204-12.PMID: 15498087 [PubMed - indexed for MEDLINE]Related articles

    49.

    Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study.

    Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, Taillefer R, Wittlin SD, Heller GV, Filipchuk N, Engel S, Ratner RE, Iskandrian AE; Detection of Ischemia in Asymptomatic Diabetics Investigators.

    Diabetes Care. 2004 Aug;27(8):1954-61. Erratum in: Diabetes Care. 2005 Feb;28(2):504. PMID: 15277423 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the Detection of Ischemia in Asymptomatic Diabetics-brachial artery reactivity study).

    Papaioannou GI, Seip RL, Grey NJ, Katten D, Taylor A, Inzucchi SE, Young LH, Chyun DA, Davey JA, Wackers FJ, Iskandrian AE, Ratner RE, Robinson EC, Carolan S, Engel S, Heller GV.

    Am J Cardiol. 2004 Aug 1;94(3):294-9.PMID: 15276091 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...